Common Stock Reserved For Issuance

3 Months Ended

Mar. 31, 2020

Equity [Abstract]

Common Stock Reserved For Issuance

Note 8.   COMMON STOCK RESERVED FOR ISSUANCE

Common stock has been reserved for the following potential future issuances:

	As of March 31, 2020		As of December 31, 2019
Shares underlying outstanding stock options		626,532		579,731
Shares available for future stock option grants		476,369		230,952
Exchange of Vaccinex Products, LP units		1,173,500		1,173,500
Conversion of VX3 units		1,318,797		1,318,797
Total shares of common stock reserved		3,595,198		3,302,980